Stereotaxis, Inc. (NASDAQ:STXS) today announced the completion of the first 50 clinical procedures using the Company’s new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia. Positive initial results with […]
Home» Posts tagged "STXS"
Stereotaxis Inc. (STXS): Impending Bounce Play
Stereotaxis Inc. (Nasdaq: STXS) announced Monday after-hours that its loss in the second quarter widened to $9.7 million, compared with a loss of $3.9 million in the second quarter of 2010. The St. Louis medical device maker reported revenue of $11.6 million for the quarter ended June 30, down 23 percent from $15 million a […]